References
- Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014;142:90–98.
- Epperson C, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013;98:3829–3838.
- Greendale, GA, Derby CA, Maki PM. Perimenopause and cognition. Obstet Gynecol Clin North Am. 2011;3:519–535.
- Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35:8–30.
- Maki PM, Weber MT. Do menopausal symptoms account for the declines in cognitive function during the menopausal transition? In: Brinton RD, Genazzani AR, Simoncini T, Stevenson JC. (eds) Sex Steroids' Effects on Brain, Heart and Vessels. ISGE Series. Springer International Publishing, 2019.
- Matyi JM, Rattinger GB, Schwartz S, Buhusi M, Tschanz JT. Lifetime estrogen exposure and cognition in late life: the Cache County Study. Menopause. 2019;26:1366–1374.
- Reuben R, Karkaby L, NcNamee C, Phillips NA, Einstein G. Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline? Climacteric. 2021;24:321–332.
- Weber MT, Rubin LH, Schroeder R, Steffenella T, Maki PM. Cognitive profiles in perimenopause: hormonal and menopausal symptom correlates. Climacteric. 2021;24:401–409.
- Orprayoona N, Santibenchakul S, Hemrungrojn S, et al. Effect of surgical menopause and frontal lobe cognitive function. Climacteric. 2021;24:389–393.
- Chaikittisilpa S, Orprayoona N, Santibenchakul S, et al. Prevalence of mild cognitive impairment in surgical menopause: subtypes and associated factors. Climacteric. 2021;24:394–400.
- Baumgartner NE, Daniels JM. Estrogen receptor α: a critical role in successful female cognitive aging. Climacteric. 2021;24:333–339.
- Prakapenka AV, Korol DL. Estradiol selectively regulates metabolic substrates across memory systems in models of menopause. Climacteric. 2021;24:366–372.
- Baber RJ, Panay N, Fenton A, the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19:109–150.
- Kim YJ, Brinton RD. Precision hormone therapy: identification of positive responders. Climacteric. 2021;24:350–358.
- Li Y, Dreher J-C. A review of the impact of hormone therapy on prefrontal structure and function at menopause. Climacteric. 2021;24:340–349.
- Hugenschmidt CE, Duran T, Espeland MA. Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment. Climacteric. 2021;24:359–365.
- Maki PM, Weber MT. A research primer for studies of cognitive changes across the menopause transition. Climacteric. 2021;24:382–388.
- Biamonte-Nelson HA, Bernaud VE, Koebele SV. Menopause hormone therapy and cognition: maximizing translation from preclinical research. Climacteric. 2021;24:373–381.